Related references
Note: Only part of the references are listed.N6-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression
Jianbo Tian et al.
GUT (2020)
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer
Jody Vykoukal et al.
NATURE COMMUNICATIONS (2020)
Cistrome Data Browser: expanded datasets and new tools for gene regulatory analysis
Rongbin Zheng et al.
NUCLEIC ACIDS RESEARCH (2019)
CADD: predicting the deleteriousness of variants throughout the human genome
Philipp Rentzsch et al.
NUCLEIC ACIDS RESEARCH (2019)
MiR-29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125
Chen Liang et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell invasion and Metastasis
Vasiliki Gkretsi et al.
FRONTIERS IN ONCOLOGY (2018)
Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations
Jiang Chang et al.
NATURE COMMUNICATIONS (2018)
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
Andrew McGuigan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Caveolin-1 and Caveolin-2 Can Be Antagonistic Partners in inflammation and Beyond
Cecilia Jacques Goncalves de Almeida
FRONTIERS IN IMMUNOLOGY (2017)
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants
Nilah M. Ioannidis et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Forcing throuch Tumor Metastasis: The Interplay between Tissue Rigidity and Epithelial-Mesenchymal Transition
Spencer C. Wei et al.
TRENDS IN CELL BIOLOGY (2016)
Predicting effective microRNA target sites in mammalian mRNAs
Vikram Agarwal et al.
ELIFE (2015)
Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
Chengliang Dong et al.
HUMAN MOLECULAR GENETICS (2015)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
The extracellular matrix modulates the hallmarks of cancer
Michael W. Pickup et al.
EMBO REPORTS (2014)
Genome-wide association study of survival in patients with pancreatic adenocarcinoma
Chen Wu et al.
GUT (2014)
Functional annotation of noncoding sequence variants
Graham R. S. Ritchie et al.
NATURE METHODS (2014)
Prognostic factors related with survival in patients with pancreatic adenocarcinoma
Ahmet Bilici
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Prognostic role of caveolin in breast cancer: A meta-analysis
Xuelei Ma et al.
BREAST (2013)
Recent progress in pancreatic cancer
Christopher L. Wolfgang et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
E-cadherin-integrin crosstalk in cancer invasion and metastasis
Marta Canel et al.
JOURNAL OF CELL SCIENCE (2013)
DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows
Maria D. Paraskevopoulou et al.
NUCLEIC ACIDS RESEARCH (2013)
Annotation of functional variation in personal genomes using RegulomeDB
Alan P. Boyle et al.
GENOME RESEARCH (2012)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Novel Insights into the Role of Caveolin-2 in Cell- and Tissue-Specific Signaling and Function
Grzegorz Sowa
BIOCHEMISTRY RESEARCH INTERNATIONAL (2011)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
Sonja Gillen et al.
PLOS MEDICINE (2010)
Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
S. E. Elsheikh et al.
BRITISH JOURNAL OF CANCER (2008)
Tumor-node-metastasis staging of pancreatic adenocarcinoma
Matthew H. G. Katz et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Caveats of caveolin-1 in cancer progression
Elke Burgermeister et al.
CANCER LETTERS (2008)
Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis
Kay Savage et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Caveolae: Mining little caves for new cancer targets
LA Carver et al.
NATURE REVIEWS CANCER (2003)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)
Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation
A Fong et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Upregulation of caveolin in multidrug resistant cancer cells: functional implications
Y Lavie et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Share Paper
